Systematic exploration of natural and synthetic flavonoids for the inhibition of Staphylococcus aureus biofilms

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 19434-19451

  Manner, Suvi ^a   Skogman, Malena ^a   Goeres, Darla ^b   Vuorela, Pia ^a,c   Fallarero, Adyary ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b MONTANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antibacterial; Bioactivity; Biofilms; Chalcones; Flavanones; Flavans; Flavones; Flavonoids; Staphylococcus aureus

Indexed keywords

3,5,7 TRIHYDROXY 2 PHENYLCHROMEN 4 ONE; 4 [6 HYDROXYSPIRO (1,2,3,3A,9A PENTAHYDROCYCLOPENTA[1,2 B]CHROMANE 9,1' CYCLOPENTANE) 3A YL]BENZENE 1,3 DIOL; 5,7 DIHYDROXY 8 (3 METHYLBUT 2 ENYL) 2 PHENYLCHROMAN 4 ONE; 6 CHLORO 4 (6 CHLORO 7 HYDROXY 2,4,4 TRIMETHYLCHROMAN 2 YL)BENZENE 1,3 DIOLAND; ANTIINFECTIVE AGENT; CHALCONE DERIVATIVE; DIHYDROFLAVONOL DERIVATIVE; FLAVAN DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; ISOFLAVONOID; ISOLIQUIRITIGENIN; NARINGENIN; NATURAL PRODUCTS AND THEIR SYNTHETIC DERIVATIVES; NEOFLAVONOID DERIVATIVE; PENTETIC ACID; PHYTOESTROGEN; QUERCETIN; UNCLASSIFIED DRUG;

ACYLATION; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CELL DENSITY; CONCENTRATION RESPONSE; DRUG CLASSIFICATION; DRUG DESIGN; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; HYDROXYLATION; IC 50; IN VITRO STUDY; IN VIVO STUDY; IONIC STRENGTH; MEMBRANE POTENTIAL; MICROBIOLOGICAL PARAMETERS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR LIBRARY; NONHUMAN; PHENOTYPE; PORPHYROMONAS GINGIVALIS; PRENYLATION; RALSTONIA SOLANACEARUM; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; BIOFILMS; FLAVONOIDS; STAPHYLOCOCCUS AUREUS;

EID: 84884894197     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141019434     Document Type: Article

References (52)

1. Donlan, R.M. Biofilm formation: A clinically relevant microbiological process. Clin. Infect. Dis. 2001, 33, 1387-1392.
2. Donlan, R.M.; Costerton, J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15, 167-193.
3. Sauer, K.; Camper, A.K. Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth. J. Bacteriol. 2001, 183, 6579-6589.
4. Tote, K.; vanden Berghe, D.; Deschacht, M.; de Wit, K.; Maes, L.; Cos, P. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Int. J. Antimicrob. Agents 2009, 33, 525-531.
5. Landini, P.; Antoniani, D.; Burgess, J.G.; Nijland, R. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl. Microbiol. Biotechnol. 2010, 86, 813-823.
6. Parsek, M.R.; Singh, P.K. Bacterial biofilms: An emerging link to disease pathogenesis. Annu. Rev. Microbiol. 2003, 57, 677-701.
7. Malic, S.; Hill, K.E.; Hayes, A.; Percival, S.L.; Thomas, D.W.; Williams, D.W. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA-FISH). Microbiology 2009, 155, 2603-2611.
8. James, G.A.; Swogger, E.; Wolcott, R.; deLancey Pulcini, E.; Secor, P.; Sestrich, J.; Costerton, J.W.; Stewart, P.S. Biofilms in chronic wounds. Wound Repair Regener. 2008, 16, 37-44.
9. Hall-Stoodley, L.; Hu, F.Z.; Gieseke, A.; Nistico, L.; Nguyen, D.; Hayes, J.; Forbes, M.; Greenberg, D.P.; Dice, B.; Burrows, A.; et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006, 296, 202-211.
10. Singh, P.K.; Schaefer, A.L.; Parsek, M.R.; Moninger, T.O.; Welsh, M.J.; Greenberg, E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407, 762-764.
11. Adair, C.G.; Gorman, S.P.; Feron, B.M.; Byers, L.M.; Jones, D.S.; Goldsmith, C.E.; Moore, J.E.; Kerr, J.R.; Curran, M.D.; Hogg, G.; et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 1999, 25, 1072-1076.
12. Worthington, R.J.; Richards, J.J.; Melander, C. Small molecule control of bacterial biofilms. Org. Biomol. Chem. 2012, 10, 7457-7474.
13. Samanta, A.; Das, G.; Das, S.K. Roles of flavonoids in plants. Int. J. Pharm. Sci. Technol. 2011, 6, 12-35.
14. Kumar, B.; Sandhar, H.K.; Prasher, S.; Tiwari, P.; Salhan, M.; Sharma, P. A review of phytochemistry and pharmacology of flavonoids. Int. Pharm. Sci. 2011, 1, 25-41.
15. Cushnie, T.P.; Lamb, A.J. Recent advances in understanding the antibacterial properties of flavonoids. Int. J. Antimicrob. Agents 2011, 38, 99-107.
16. Havsteen, B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96, 67-202.
17. Alvesalo, J.; Vuorela, H.; Tammela, P.; Leinonen, M.; Saikku, P.; Vuorela, P. Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures. Biochem. Pharmacol. 2006, 71, 735-741.
18. Cushnie, T.P.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343-356.
19. Rauha, J.P.; Remes, S.; Heinonen, M.; Hopia, A.; Kähkönen, M.; Kujala, T.; Pihlaja, K.; Vuorela, H.; Vuorela, P. Antimicrobial effects of finnish plant extracts containing flavonoids and other phenolic compounds. Int. J. Food Microbiol. 2000, 56, 3-12.
20. Sandberg, M.; Määttänen, A.; Peltonen, J.; Vuorela, P.M.; Fallarero, A. Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: An approach to screening of natural antimicrobial compounds. Int. J. Antimicrob. Agents 2008, 32, 233-240.
21. Sandberg, M.E.; Schellmann, D.; Brunhofer, G.; Erker, T.; Busygin, I.; Leino, R.; Vuorela, P.M.; Fallarero, A. Pros and cons of using resazurin staining for quantification of viable Staphylococcus aureus biofilms in a screening assay. J. Microbiol. Methods 2009, 78, 104-106.
22. Skogman, M.E.; Vuorela, P.M.; Fallarero, A. Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms. J. Antibiot. 2012, 65, 453-459.
23. Fallarero, A.; Skogman, M.; Kujala, J.; Rajaratnam, M.; Moreira, V.M.; Yli-Kauhaluoma, J.; Vuorela, P. (+)-Dehydroabietic acid, an abietane-type diterpene, inhibits Staphylococcus aureus biofilms in vitro. Int. J. Mol. Sci. 2013, 14, 12054-12072.
24. Peeters, E.; Nelis, H.J.; Coenye, T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 2008, 72, 157-165.
25. Mariscal, A.; Lopez-Gigosos, R.M.; Carnero-Varo, M.; Fernandez-Crehuet, J. Fluorescent assay based on resazurin for detection of activity of disinfectants against bacterial biofilm. Appl. Microbiol. Biotechnol. 2009, 82, 773-783.
26. Cushnie, T.P.; Hamilton, V.E.; Lamb, A.J. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports. Microbiol. Res. 2003, 158, 281-289.
27. Vikram, A.; Jayaprakasha, G.K.; Jesudhasan, P.R.; Pillai, S.D.; Patil, B.S. Suppression of bacterial cell-cell signalling, biofilm formation and type III secretion system by citrus flavonoids. J. Appl. Microbiol. 2010, 109, 515-527.
28. Zeng, Z.; Qian, L.; Cao, L.; Tan, H.; Huang, Y.; Xue, X.; Shen, Y.; Zhou, S. Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 2008, 79, 119-126.
29. Vandeputte, O.M.; Kiendrebeogo, M.; Rajaonson, S.; Diallo, B.; Mol, A.; El Jaziri, M.; Baucher, M. Identification of catechin as one of the flavonoids from Combretum albiflorum bark extract that reduces the production of quorum-sensing-controlled virulence factors in Pseudomonas aeruginosa PAO1. Appl. Environ. Microbiol. 2010, 76, 243-253.
30. Zhao, X.; Mei, W.; Gong, M.; Zuo, W.; Bai, H.; Dai, H. Antibacterial activity of the flavonoids from Dalbergia odorifera on Ralstonia solanacearum. Molecules 2011, 16, 9775-9782.
31. Feldman, M.; Santos, J.; Grenier, D. Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential. J. Nat. Prod. 2011, 74, 1862-1867.
32. Avila, H.P.; Smânia, E.F.A.; Monache, F.D.; Smânia, A. Structure-activity relationship of antibacterial chalcones. Bioorg. Med. Chem. 2008, 16, 9790-9794.
33. Alvarez, M.e.L.; Zarelli, V.E.; Pappano, N.B.; Debattista, N.B. Bacteriostatic action of synthetic polyhydroxylated chalcones against Escherichia coli. Biocell 2004, 28, 31-34.
34. Li, H.Q.; Shi, L.; Li, Q.S.; Liu, P.G.; Luo, Y.; Zhao, J.; Zhu, H.L. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FABH) as antibiotics. Bioorg. Med. Chem. 2009, 17, 6264-6269.
35. Lee, J.H.; Park, J.H.; Cho, H.S.; Joo, S.W.; Cho, M.H.; Lee, J. Anti-biofilm activities of quercetin and tannic acid against Staphylococcus aureus. Biofouling 2013, 29, 491-499.
36. Pohjala, L.; Tammela, P. Aggregating behavior of phenolic compounds-A source of false bioassay results? Molecules 2012, 17, 10774-10790.
37. McGovern, S.L.; Shoichet, B.K. Kinase inhibitors: Not just for kinases anymore. J. Med. Chem. 2003, 46, 1478-1483.
38. Dürig, A.; Kouskoumvekaki, I.; Vejborg, R.M.; Klemm, P. Chemoinformatics-assisted development of new anti-biofilm compounds. Appl. Microbiol. Biotechnol. 2010, 87, 309-317.
39. Fránová, J.; Pavlík, M. Testing of antidiabetic and antioxidative effect of the flavonoid osajin in an experiment. Ceska Slov. Farm. 2007, 56, 200-204.
40. Suksamrarn, A.; Chotipong, A.; Suavansri, T.; Boongird, S.; Timsuksai, P.; Vimuttipong, S.; Chuaynugul, A. Antimycobacterial activity and cytotoxicity of flavonoids from the flowers of Chromolaena odorata. Arch. Pharm. Res. 2004, 27, 507-511.
41. Sufian, A.S.; Ramasamy, K.; Ahmat, N.; Zakaria, Z.A.; Yusof, M.I. Isolation and identification of antibacterial and cytotoxic compounds from the leaves of Muntingia calabura L. J. Ethnopharmacol. 2013, 146, 198-204.
42. Sánchez, I.; Gómez-Garibay, F.; Taboada, J.; Ruiz, B.H. Antiviral effect of flavonoids on the dengue virus. Phytother. Res. 2000, 14, 89-92.
43. Zanoli, P.; Zavatti, M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J. Ethnopharmacol. 2008, 116, 383-396.
44. Mizobuchi, S.; Sato, Y. Antifungal activities of hop bitter resins and related compounds. Agric. Biol. Chem. 1985, 49, 399-403.
45. Shen, G.; Huhman, D.; Lei, Z.; Snyder, J.; Sumner, L.W.; Dixon, R.A. Characterization of an isoflavonoid-specific prenyltransferase from Lupinus albus. Plant Physiol. 2012, 159, 70-80.
46. Chang, S.Y.; Cheng, M.J.; Peng, C.F.; Chang, H.S.; Chen, I.S. Antimycobacterial butanolides from the root of Lindera akoensis. Chem. Biodiversity 2008, 5, 2690-2698.
47. Ríos, J.L.; Recio, M.C. Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 2005, 100, 80-84.
48. Pitts, B.; Hamilton, M.A.; Zelver, N.; Stewart, P.S. A microtiter-plate screening method for biofilm disinfection and removal. J. Microbiol. Methods 2003, 54, 269-276.
49. Jensen, P.; Givskov, M.; Bjarnsholt, T.; Moser, C. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol. 2010, 59, 292-305.
50. Müller, G.; Kramer, A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J. Antimicrob. Chemother. 2008, 61, 1281-1287.
51. Zhang, J.H.; Chung, T.D.; Oldenburg, K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screening 1999, 4, 67-73.
52. Bollini, S.; Herbst, J.J.; Gaughan, G.T.; Verdoorn, T.A.; Ditta, J.; Dubowchik, G.M.; Vinitsky, A. High-throughput fluorescence polarization method for identification of fkbp12 ligands. J. Biomol. Screening 2002, 7, 526-530.